To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa2223
Peptide Name Sequence 48 from Patent US20140294942A1
Sequence VSFRVGLHEYPV
Sequence Length 12
Source Synthetic peptide
Target Organism vsv
Patent Type Patent Application
Publication Date 2014-10-02
Patent No US20140294942A1
Family Info WO/2013/036622
Patent Title ANTIVIRAL PEPTIDES EFFECTIVE AGAINST HEPATITIS C VIRUS
Comment
Abstract In certain embodiments this invention provides novel antiviral peptide(s) that are effective against positive sense RNA viruses that have an internal ribosome entry site (IRES). The peptide(s) can be used to inhibit propagation of such viruses and thereby provide a effective modality for the treatment of infections such as hepatitis C, and the like.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.